Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs James Hardie Industries plc. Ordinary Shares (JHX) Price & Performance

Hims and Hers Health IncTrade
James Hardie Industries plc. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs James Hardie Industries plc. Ordinary Shares — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while James Hardie Industries plc. Ordinary Shares trades at $25.12 (market cap $14.60B). The key difference: James Hardie Industries plc. Ordinary Shares is far larger — about 2.2× Hims and Hers Health Inc's market cap, and James Hardie Industries plc. Ordinary Shares is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and James Hardie Industries plc. Ordinary Shares for 1 Days on average.

HIMSJHX
Market Cap
$6.55B$14.60B
Volume
14,842,8147,262,924
Sector
HealthBasic Materials
52-Week High
$62.76$31.08
52-Week Low
$14.52$16.69
Typical Hold Time
21 Days1 Days
Enterprise Value
$7.25B$18.83B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

Hims & Hers Health trades at $30.92, up 4.67% on the day, amid a bearish technical signal and significant legal headwinds from multiple securities class action lawsuits. The stock shows mixed fundamentals with strong revenue growth to $2.35 billion in 2025 but a sharp reversal to a net loss of -$142 million in 2026, reflecting profitability challenges. Valuation ratios appear elevated with a P/E of 57.14 and EV/EBITDA of 205.86, while analyst consensus remains cautiously optimistic with a $32.17 price target.

The outlook is clouded by legal risks and recent earnings misses, though the company's gross margin of 68.43% indicates underlying business strength. Investment opportunity hinges on resolving regulatory scrutiny and returning to profitability, but near-term volatility is likely. Key risks include the FTC lawsuit outcome and sustained negative cash flow, demanding careful risk assessment by investors.

James Hardie Industries plc. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HIMS
89% Buy11% Sell
Avg holding period · 21 Days
JHX

No sentiment data available yet.

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS →

About James Hardie Industries plc. Ordinary Shares

James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.

Read more on JHX →